SOCIETY

Oxford/AstraZeneca COVID shot less effective against South African variant

British drugmaker AstraZeneca AZN.L said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19.